Literature DB >> 15960993

Does prevention save costs? Considering deferral of the expensive last year of life.

Afschin Gandjour1, Karl Wilhelm Lauterbach.   

Abstract

Published cost-effectiveness analyses may overstate the cost-effectiveness ratio of preventive care if they do not explicitly model the costs of the last year of life, which is postponed by prevention. To determine the degree of overestimation, the authors built a statistical model using Medicare expenditure data on survivors and decedents. The model shows that the cost-effectiveness ratio of prevention may decrease by up to US$ 11,000 per quality-adjusted life year saved when expenditure data on the last year life are used. The model is able to explain more than half of the median cost increase of published cost-effectiveness analyses on clinical preventive services.

Mesh:

Year:  2005        PMID: 15960993     DOI: 10.1016/j.jhealeco.2004.11.009

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  11 in total

1.  Standardizing the inclusion of indirect medical costs in economic evaluations.

Authors:  Pieter H M van Baal; Albert Wong; Laurentius C J Slobbe; Johan J Polder; Werner B F Brouwer; G Ardine de Wit
Journal:  Pharmacoeconomics       Date:  2011-03       Impact factor: 4.981

2.  Cost-effectiveness of referrals to high-volume hospitals: an analysis based on a probabilistic Markov model for hip fracture surgeries.

Authors:  Afschin Gandjour; Eva-Julia Weyler
Journal:  Health Care Manag Sci       Date:  2006-11

Review 3.  Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?

Authors:  David R Rappange; Pieter H M van Baal; N Job A van Exel; Talitha L Feenstra; Frans F H Rutten; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

4.  Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries.

Authors:  Hamraz Mokri; Ingelin Kvamme; Linda de Vries; Matthijs Versteegh; Pieter van Baal
Journal:  Eur J Health Econ       Date:  2022-08-04

Review 5.  Macroeconomic implications of population ageing and selected policy responses.

Authors:  David E Bloom; Somnath Chatterji; Paul Kowal; Peter Lloyd-Sherlock; Martin McKee; Bernd Rechel; Larry Rosenberg; James P Smith
Journal:  Lancet       Date:  2014-11-06       Impact factor: 79.321

6.  Cost-effectiveness of preventive interventions to reduce alcohol consumption in Denmark.

Authors:  Astrid Ledgaard Holm; Lennert Veerman; Linda Cobiac; Ola Ekholm; Finn Diderichsen
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

Review 7.  Economic evaluation of health promotion for older people-methodological problems and challenges.

Authors:  Kai Huter; Ewa Kocot; Katarzyna Kissimova-Skarbek; Katarzyna Dubas-Jakóbczyk; Heinz Rothgang
Journal:  BMC Health Serv Res       Date:  2016-09-05       Impact factor: 2.655

8.  Future Costs in Cost-Effectiveness Analyses: Past, Present, Future.

Authors:  Linda M de Vries; Pieter H M van Baal; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.981

9.  The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening.

Authors:  I M C M de Kok; J J Polder; J D F Habbema; L-M Berkers; W J Meerding; M Rebolj; M van Ballegooijen
Journal:  Br J Cancer       Date:  2009-04-21       Impact factor: 7.640

10.  Review of Australian health economic evaluation - 245 interventions: what can we say about cost effectiveness?

Authors:  Kim Dalziel; Leonie Segal; Duncan Mortimer
Journal:  Cost Eff Resour Alloc       Date:  2008-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.